← FDA MEDWATCH
FDA (US) · FDA PRESS RELEASEJune 16, 2026
FDA Broadens Access to Over-the-Counter Naloxone Nasal Spray for Opioid Overdose
What this record is not
Item details are published by the U.S. FDA on fda.gov; SPEQ surfaces them for reference and is not affiliated with or endorsed by the FDA. The authoritative notice is on fda.gov.
Item type
FDA Press Release
Published
June 16, 2026
Source
U.S. FDA (MedWatch / press releases)
READ THE FULL FDA NOTICE
The complete FDA notice — the affected products, the action required, and any recall detail — is published on fda.gov. SPEQ surfaces and indexes it for reference; the authoritative notice lives on fda.gov.
View on fda.gov →